Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Systemic Lupus Erythematosus (SLE)
NCT00119678Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2005
- Primary completion
- Nov 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 15
01
Overview
A Phase 2 trial of abatacept in systemic lupus erythematosus (SLE), sponsored by Bristol Myers Squibb. Started Sep 2005; status: completed.
02
Drugs
abatacept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00119678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119678.